Obstetrics & Gynecology:
Greater Maternal Weight and the Ongoing Risk of Neural Tube Defects After Folic Acid Flour Fortification
Ray, Joel G. MD, MSc*; Wyatt, Philip R. MD, PhD†; Vermeulen, Marian J. BScN, MHSc‡; Meier, Chris BSc§; Cole, David E. C. MD, PhD¶
From the *Department of Medicine, St. Michael's Hospital, University of Toronto; †Department of Genetics, North York General Hospital; ‡Institute for Clinical Evaluative Sciences, Sunnybrook and Women's College Health Sciences Centre, University of Toronto; §Ontario Maternal Serum Screening Database Department, Genetics Programme, North York General Hospital; and ¶Departments of Laboratory Medicine and Pathobiology, Medicine and Paediatrics (Genetics), University of Toronto, Toronto, Ontario, Canada.
Supported by the Spina Bifida and Hydrocephalus Association of Canada and the physicians of Ontario, through the Physicians' Services Incorporated Foundation.
The authors thank both the Ontario provincial laboratories and genetics clinics for contributing data to the Ontario MSS Database.
Reprints are not available. Address correspondence to: Joel G. Ray, MD, MSc, Department of Medicine, St. Michael's Hospital, University of Toronto, 30 Bond Street, Toronto, Ontario M5B 1W8, Canada; e-mail: email@example.com.
Received August 20, 2004. Received in revised form October 12, 2004. Accepted October 14, 2004.
OBJECTIVE: Maternal obesity is likely a risk factor for neural tube defects (NTDs). By late 1997, it became mandatory in Canada that all refined wheat flour be fortified with folic acid. Because overweight women may consume greater quantities of refined wheat flour, we questioned whether their risk of NTD changed after flour fortification.
METHODS: A retrospective population-based study was conducted between 1994 and late 2000. We included all Ontarian women who underwent antenatal maternal screening at 15 to 20 weeks of gestation. Self-declared maternal date of birth, ethnicity, current weight, and the presence of pregestational diabetes mellitus were recorded in a standardized fashion on the maternal screening requisition sheet. The presence of NTDs was systematically detected both antenatally and postnatally. The risk of open NTD was evaluated across maternal weight quartiles and deciles, and an interaction between greater maternal weight and the presence of flour fortification was tested using multiple logistic regression analysis.
RESULTS: A total of 292 open NTDs were detected among 420,362 women. The adjusted odds ratio (OR) for NTD was 1.2 (95% confidence interval [CI] 1.1–1.3) per 10-kg incremental rise in maternal weight. Comparing the highest with the lowest quartile of maternal weight, the adjusted OR for NTD was 2.6 (95% CI 1.8–4.0). A similar finding was observed for the highest compared with lowest weight deciles (adjusted OR 3.3, 95% CI 1.7–6.2). The interaction between elevated maternal weight and the presence of folic acid flour fortification was of borderline significance (P = .09). Before fortification, greater maternal weight was associated with a modestly increased risk of NTD (adjusted OR 1.4, 95% CI 1.0–1.8); after flour fortification, this effect was more pronounced (adjusted OR 2.8, 95% CI 1.2–6.6).
CONCLUSION: These data emphasize the higher risk of NTD associated with increased maternal weight, even after universal folic acid flour fortification. Beyond periconceptional folic acid use, consideration should be given to testing whether prepregnancy weight reduction is an independent means of preventing NTD.
LEVEL OF EVIDENCE: II-2
Maternal obesity is likely one of several risk factors for neural tube defects (NTDs)1–3.Greater mean daily consumption of sucrose-containing and high-glycemic index foods was recently shown to be associated with an increased risk of NTD, especially among obese women.4 At the same time, greater physical activity was associated with a lower risk of NTD.5 Commercially available white–wheat-flour breads and cereals have a high glycemic index, a standardized measure of the postprandial rise in serum glucose concentrations per 50 g of carbohydrate,6 and are associated with a higher risk of obesity7 and non–insulin-dependent diabetes mellitus.8
Randomized clinical trials have demonstrated at least a 50% reduction in the relative risk of NTD with periconceptional folic acid supplement use.9 Moreover, after the introduction of mandatory folic acid fortification of all refined wheat flour milled in the United States and Canada in late 1997, an impressive decline was observed in the prevalence of open NTDs,10–12 along with a significant rise in blood folate concentrations.13
Women who ingest greater quantities of white–wheat-flour foods before conception are at increased risk for obesity14 and, perhaps, fetal NTD.4 At the same time, these individuals would be expected to ingest greater quantities of folic acid than nonobese women in the context of fortification. We examined whether the risk of open NTD, in relation to maternal obesity, changed after the introduction of Canada's folic acid fortification program.
We performed a retrospective population-based study and included all Ontarian women who underwent antenatal maternal screening between 1994 and late 2000, as described elsewhere.11 Briefly, since 1993, standardized maternal screening was made available to all women at 15 to 20 weeks of gestation through a physician or midwife, with a mean rate of use of more than 70%. Self-declared maternal date of birth, ethnicity, weight, and the presence of pregestational diabetes mellitus were recorded in a standardized fashion on the maternal screening requisition sheet, completed at the time of screening. Open NTD cases were detected antenatally by ultrasonography or fetal autopsy, or postnatally through data linkage of the mother's Ontario health insurance number with that of her infant during the delivery hospitalization through the Canadian Institute for Health Information Discharge Abstract Database.11
Means and standard deviations (SDs) were computed and compared using an unpaired t test. The trend in the prevalence of open NTD across maternal weight quartiles (Q1–Q4) and deciles (D1–D10), respectively, was evaluated using a Mantel χ2 test.15 Crude and adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were derived from logistic regression analysis, with Q1 and D1 as the respective referents. We adjusted for maternal age (1-year increments), maternal race (Black, Asian, Hispanic or First Nations [Native North American], or Other compared with White), pregestational diabetes, and year of screening. The same model was used to examine the effect of maternal weight in 10-kg increments on the associated risk of NTD. Logistic regression analysis was also used to test for a significant interaction term between high maternal weight (ie, greater than Q4 compared with Q1–Q3) and folic acid food fortification (ie, before compared with after January 1998).11 Finally, we compared the risk of NTD before and after fortification, stratified by weight quartile, adjusting for maternal age, ethnicity, and pregestational diabetes mellitus; the corresponding relative odds reduction was calculated as ([1 –OR] × 100).
All variables were included in the model a priori, and statistical significance was set at a 2-tailed P < .05. Analyses were performed using SAS 8.0 (SAS Institute, Cary, NC). The study was done in accordance with a research protocol approved through the Ministry of Health and Long-term Care in Ontario, as well as the Research Ethics Board of St. Michael's Hospital, and participant identifiers were removed from the data set before analysis.
A total of 420,362 women underwent maternal screening during the period of study, of whom 406,191 (97%) had available weight data (Table 1). The characteristics of the women with and without an NTD-affected pregnancy are presented in Table 1. Of 292 reported NTDs, 213 (73.0%) were identified antenatally. Women with an NTD-affected pregnancy had a greater mean weight ± SD (70.8 ± 15.6 kg) than unaffected mothers (66.9 ± 14.4 kg), a difference of 3.9 kg (95% CI 2.2–5.6; P < .001) (Table 1).
For each 10-kg increase in maternal weight, the crude and adjusted odds ratios were 1.2 (95% CI 1.1–1.3). There was a significant trend in the rate of NTDs according to weight quartiles (P < .001) and deciles (P < .001) (Table 2, Fig. 1). The associated risk for an NTD was significantly higher in each of the upper 3 quartiles, relative to a Q1 weight less than 57.1 kg, and was most pronounced for a Q4 weight more than 73.6 kg (adjusted OR 2.1, 95% CI 1.4–3.2) (Table 2). When maternal body weight was divided into deciles, there was again a significantly higher associated risk of NTD in the upper deciles, especially the highest category of maternal weight greater than 85.6 kg (adjusted OR 3.3, 95% CI 1.7–6.2) (Table 2, Fig. 1).
The interaction term between elevated maternal weight and the presence of folic acid flour fortification was of borderline significance (P = .09). Before fortification, a maternal weight at Q4 or greater was associated with a slightly increased risk of NTD (adjusted OR 1.4, 95% CI 1.0–1.8), whereas after fortification, the risk was more pronounced (adjusted OR 2.8, 95% CI 1.2–6.6) (Table 3). Moreover, when stratified by weight, women in Q4 had a smaller associated reduction in the relative odds of NTD (44%) than women in Q1 (68%), Q2 (70%) or Q3 (90%) (Table 4).
We observed a higher risk of NTD associated with increased maternal weight among women who underwent maternal screening. Despite the introduction of folic acid flour fortification, women of increased weight have remained at significantly higher risk of NTD compared with those in lower weight categories.
Our study is limited by absence of information on folic acid tablet supplementation, and we could only approximate the point at which folic acid flour fortification became clinically significant.11–13 We were also unaware of who may have dieted periconceptionally, in an effort to lose weight, thus restricting their folic acid intake; it is possible that this practice was more common among overweight women. Similarly, obese women tend to consume fewer folate-containing fruits and vegetables.16
Use of self-reported weight has been validated in previous epidemiologic studies,17 with small variations between self-reported and measured weight in pregnancy.18,19 Although we did not measure height, maternal weight seems to approximate body mass index (BMI) quite well (correlation coefficient 0.85–0.90).20,21 Maternal weight measured at 15 to 20 weeks of gestation also likely provides only an approximation of prepregnancy weight. In this study, maternal weight was estimated at about the same gestational age in all participants, thereby minimizing variability. Second trimester BMI has been shown to be highly correlated with prepregnancy BMI22; nonetheless, because there is an inverse relationship between prepregnancy BMI and weight gain in the first and second trimesters of pregnancy,23 we may have underestimated the true relationship between maternal weight and the risk of abnormal closure of the neural tube at 22 to 28 days postconception.
The observed association between maternal obesity and NTD is in keeping with other studies.1–3 Although we did not obtain information on maternal dietary patterns, others have found greater caloric intake to be a risk factor for NTD.4 In a Californian population-based case-control study of the mothers of 454 NTD-affected fetuses and 462 unaffected controls, the risk of NTD was highest among women whose average dietary glycemic index was in the upper compared with lower quartile (adjusted OR 1.9, 95% CI 1.3–2.7).4 This was especially pronounced in those women whose periconceptional BMI was greater than 29 kg/m2 (adjusted OR 4.0, 95% CI 1.0–15.7). In addition to dietary intake, maternal inactivity too has been associated with higher NTD risk.5 This is especially concerning, given current rates of obesity of 6%, 11%, and 15% among North American women aged 12–19 years, 20–29 years, and 30–39 years, respectively.24 The corresponding rates of sedentary lifestyle, defined as a Physical Activity Index below 1.5 kcal/(kg · d), are 39%, 53%, and 58%.24 Thus, in addition to the other recognized adverse effects of obesity on a woman's health both during25,26 and after27 pregnancy, is the ongoing higher risk of NTDs.
These novel data emphasize the ongoing need to encourage proper intake of folic acid periconceptionally, especially among women who are overweight. Whether these women require greater amounts of folic acid remains unknown. Consideration should also be given to the study of prepregnancy weight reduction as a means of preventing NTDs. The simplest and most pragmatic approach might be to promote lower energy intake7 and greater energy expenditure (ie, exercise),28 starting at an early age.29
1. Watkins ML, Scanlon KS, Mulinare J, Khoury MJ. Is maternal obesity a risk factor for anencephaly and spina bifida? Epidemiology 1996;7:507–12.
2. Werler MM, Louik C, Shapiro S, Mitchell AA. Prepregnant weight in relation to risk of neural tube defects. JAMA 1996;275:1089–92.
3. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics 2003;111:1152–8.
4. Shaw GM, Quach T, Nelson V, Carmichael SL, Schaffer DM, Selvin S, et al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr 2003;78:972–8.
5. Carmichael SL, Shaw GM, Neri E, Schaffer DM, Selvin S. Physical activity and risk of neural tube defects. Matern Child Health J 2002;6:151–7.
6. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A, et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 2002;76:266S–73S.
7. Ludwig DS. Dietary glycemic index and obesity. J Nutr 2000;130(suppl):280S–3S.
8. Willett W, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr 2002;76:274S–80S.
9. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001;CD001056.
10. Honein MA, Paulozzi LJ, Mathews TJ, Erickson JD, Wong LY. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001;285:2981–6.
11. Ray JG, Meier C, Vermeulen MJ, Boss S, Wyatt PR, Cole DE. Association of neural tube defects and folic acid food fortification in Canada. Lancet 2002;360:2047–8.
12. Persad VL, Van den Hof MC, Dube JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002;167:241–5.
13. Ray JG, Vermeulen MJ, Boss SC, Cole DE. Increased red cell folate concentrations in women of reproductive age after Canadian folic acid food fortification. Epidemiology 2002;13:238–40.
14. Lagiou P, Tamimi RM, Mucci LA, Adami HO, Hsieh CC, Trichopoulos D. Diet during pregnancy in relation to maternal weight gain and birth size. Eur J Clin Nutr 2004;58:231–7.
15. Schlesselman S. Case-control studies: design, conduct, analysis. New York (NY): Oxford University Press; 1982.
16. Serdula MK, Byers T, Mokdad AH, Simoes E, Mendlein JM, Coates RJ. The association between fruit and vegetable intake and chronic disease risk factors. Epidemiology 1996;7:161–5.
17. Spencer EA, Appleby PN, Davey GK, Key TJ. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002;5:561–5.
18. Engstrom JL, Paterson SA, Doherty A, Trabulsi M, Speer KL. Accuracy of self-reported height and weight in women: an integrative review of the literature. J Midwifery Womens Health 2003;48:338–45.
19. Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, et al. Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology 1999;10:774–7.
20. Florey Cdu V. The use and interpretation of ponderal index and other weight-height ratios in epidemiological studies. J Chronic Dis 1970;23:93–103.
21. Watson PE, Watson ID, Batt RD. Obesity indices. Am J Clin Nutr 1979;32:736–7.
22. Abrams B, Carmichael S, Selvin S. Factors associated with the pattern of maternal weight gain during pregnancy. Obstet Gynecol 1995;86:170–6.
23. Abrams B, Selvin S. Maternal weight gain pattern and birth weight. Obstet Gynecol 1995;86:163–9.
24. Tanuseputro P, Manuel DG, Leung M, Nguyen K, Johansen H; Canadian Cardiovascular Outcomes Research Team. Risk factors for cardiovascular disease in Canada. Can J Cardiol 2003;19:1249–59.
25. O'Brien TE, Ray JG, Chan WS. Systematic overview of the association between elevated maternal body mass index and the risk of preeclampsia. Epidemiology 2003;14:368–74.
26. Stephansson O, Dickman PW, Johansson A, Cnattingius S. Maternal weight, pregnancy weight gain, and the risk of antepartum stillbirth. Am J Obstet Gynecol 2001;184:463–9.
27. Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Public Health 2001;22:355–75.
28. Ross R, Janssen I, Tremblay A. Obesity reduction through lifestyle modification. Can J Appl Physiol 2000;25:1–18.
29. McCrindle BW. Cardiovascular risk factors in adolescents: relevance, detection, and intervention. Adolesc Med 2001;12:147–62.
This article has been cited 44 time(s).
Birth Defects Research Part A-Clinical and Molecular TeratologyTeratology public affairs committee position paper: Maternal obesity and pregnancyBirth Defects Research Part A-Clinical and Molecular Teratology
Seminars in Fetal & Neonatal MedicineObesity in pregnancy: prevalence and metabolic consequencesSeminars in Fetal & Neonatal Medicine
Bjog-An International Journal of Obstetrics and GynaecologyMaternal obesity in pregnancy: is it time for meaningful research to inform preventive and management strategies?Bjog-An International Journal of Obstetrics and Gynaecology
Obstetrics and Gynecology
Management of obesity in pregnancy
Obstetrics and Gynecology, 109(2):
Journal of Nutritional Science and Vitaminology
Folate Status in Young Overweight and Obese Women: Changes Associated with Weight Reduction and Increased Folate Intake
Journal of Nutritional Science and Vitaminology, 55(2):
Birth Defects Research Part A-Clinical and Molecular TeratologyMaternal Obesity and Morbid Obesity: the Risk for Birth Defects in the OffspringBirth Defects Research Part A-Clinical and Molecular Teratology
International Journal of Morphology
Relation Between Levels of Folic acid, Vitamin B12 and Maternal Homocysteine with Neural Tube Defects and Cleft Lip
International Journal of Morphology, 26(4):
Diabetes & MetabolismOptimizing the outcome of pregnancy in obese women: From pregestational to long-term managementDiabetes & Metabolism
Seminars in Fetal & Neonatal MedicineObesity, gestational diabetes and pregnancy outcomeSeminars in Fetal & Neonatal Medicine
Obstetrics and Gynecology Clinics of North AmericaPregnancy and ObesityObstetrics and Gynecology Clinics of North America
Bjog-An International Journal of Obstetrics and GynaecologyThe short- and long-term implications of maternal obesity on the mother and her offspringBjog-An International Journal of Obstetrics and Gynaecology
Archives of Pediatrics & Adolescent Medicine
Prepregnancy obesity as a risk factor for structural birth defects
Archives of Pediatrics & Adolescent Medicine, 161(8):
American Journal of Clinical NutritionVitamin B-12 and neural tube defects: the Canadian experienceAmerican Journal of Clinical Nutrition
Human ReproductionThe preconceptual contraception paradigm: obsity and infertilityHuman Reproduction
International Journal of Gynecology & ObstetricsMetabolic syndrome and risk of fetal neural tube defectsInternational Journal of Gynecology & Obstetrics
Annual Review of NutritionMaternal obesity, metabolism and pregnancy outcomesAnnual Review of Nutrition
Birth Defects Research Part A-Clinical and Molecular TeratologyBirth defects in uncles and aunts from Irish families with neural tube defectsBirth Defects Research Part A-Clinical and Molecular Teratology
European Heart JournalProtective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern NetherlandsEuropean Heart Journal
Jognn-Journal of Obstetric Gynecologic and Neonatal NursingFolic acid supplementation among diabetic, overweight, or obese women of childbearing ageJognn-Journal of Obstetric Gynecologic and Neonatal Nursing
Jama-Journal of the American Medical Association
Maternal Overweight and Obesity and the Risk of Congenital Anomalies A Systematic Review and Meta-analysis
Jama-Journal of the American Medical Association, 301(6):
Paediatric and Perinatal EpidemiologyEffect of folic acid fortification on the incidence of neural tube defectsPaediatric and Perinatal Epidemiology
Australian and New Zealand Journal of Public Health
Assessing the case for mandatory folate fortification: policy-making in the face of scientific uncertainties
Australian and New Zealand Journal of Public Health, 29(4):
Folic acid: a public-health challenge
Journal of Human Nutrition and Dietetics
Association between body mass index and nutrient intakes in early pregnancy
Journal of Human Nutrition and Dietetics, 19(4):
Diabetes Obesity & MetabolismCan we prevent diabetic birth defects with micronutrients?Diabetes Obesity & Metabolism
Birth Defects Research Part A-Clinical and Molecular TeratologyPrevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: Survey results from a Teratogen Information ServiceBirth Defects Research Part A-Clinical and Molecular Teratology
Bulletin De L Academie Nationale De Medecine
Pregnancy and overweight : underestimated consequences ?
Bulletin De L Academie Nationale De Medecine, 192(4):
Revista De Saude Publica
Effects of folic acid fortification on the prevalence of neural tube defects
Revista De Saude Publica, 43(4):
American Journal of Obstetrics and GynecologyMaternal obesity and risk of neural tube defects: a metaanalysisAmerican Journal of Obstetrics and Gynecology
Schizophrenia BulletinSecondary Effects of Antipsychotics: Women at Greater Risk Than MenSchizophrenia Bulletin
Public Health Nutrition
Public Health Nutrition, 10(8):
Public Health NutritionIn this issue Testing, testingPublic Health Nutrition
Jognn-Journal of Obstetric Gynecologic and Neonatal NursingCaring for obese pregnant womenJognn-Journal of Obstetric Gynecologic and Neonatal Nursing
Acta PaediatricaMaternal body mass index and the association between folic acid supplements and neural tube defectsActa Paediatrica
Birth Defects Research Part A-Clinical and Molecular TeratologyMaternal obesity, folate intake, and neural tube defects in offspringBirth Defects Research Part A-Clinical and Molecular Teratology
Nutrition Research and PracticeDeterminants of neural tube defect (NTD)-protective circulating concentrations of folate in women of child-bearing age in the US post-folic acid fortification eraNutrition Research and Practice
Obesity FactsMaternal Obesity and Pre-Pregnancy Folic Acid SupplementationObesity Facts
American Journal of Obstetrics and GynecologyThe impact of folic acid intake on the association among diabetes mellitus, obesity, and spina bifidaAmerican Journal of Obstetrics and Gynecology
Does maternal Helicobacter pylori infection increase the risk of occurrence of neural tube defects in newborns in Northern Iran?
Journal of Obstetrics and GynaecologyPregnancy management following bariatric surgeryJournal of Obstetrics and Gynaecology
EpidemiologyTrends in Obesity in PregnancyEpidemiology
Clinical Obstetrics and GynecologyNutrition and PregnancyClinical Obstetrics and Gynecology
Current Opinion in Obstetrics and GynecologyObesity and reproduction: impact and interventionsCurrent Opinion in Obstetrics and Gynecology
© 2005 The American College of Obstetricians and Gynecologists